Jundishapur Journal of Microbiology

Published by: Kowsar

A Low Prevalence of Inducible Macrolide, Lincosamide, and Streptogramin B Resistance Phenotype among Methicillin-Susceptible Staphylococcus aureus Isolated from Malaysian Patients and Healthy Individuals

Asma Mesbah Elkammoshi 1 , Hamed Ghasemzadeh-Moghaddam 1 , 2 , Syafinaz Amin Nordin 1 , Niazlin Mohd Taib 1 , Suresh Kumar Subbiah 1 , Vasanthakumari Neela 1 and Rukman Awang Hamat 1 , *
Authors Information
1 Faculty of Medicine and Health Sciences, Department of Medical Microbiology and Parasitology, Universit Putra Malaysia, Serdang, Selangor, Malaysia
2 Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, IR Iran
Article information
  • Jundishapur Journal of Microbiology: October 01, 2016, 9 (10); e37148
  • Published Online: September 10, 2016
  • Article Type: Research Article
  • Received: February 16, 2016
  • Revised: August 24, 2016
  • Accepted: September 5, 2016
  • DOI: 10.5812/jjm.37148

To Cite: Mesbah Elkammoshi A, Ghasemzadeh-Moghaddam H, Amin Nordin S, Mohd Taib N, Kumar Subbiah S, et al. A Low Prevalence of Inducible Macrolide, Lincosamide, and Streptogramin B Resistance Phenotype among Methicillin-Susceptible Staphylococcus aureus Isolated from Malaysian Patients and Healthy Individuals, Jundishapur J Microbiol. 2016 ; 9(10):e37148. doi: 10.5812/jjm.37148.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999; 27(5): 887-92[PubMed]
  • 2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004; 39(3): 309-17[DOI][PubMed]
  • 3. Kaspar U, Kriegeskorte A, Schubert T, Peters G, Rudack C, Pieper DH, et al. The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ Microbiol. 2016; 18(7): 2130-42[DOI][PubMed]
  • 4. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004; 364(9435): 703-5[DOI][PubMed]
  • 5. Ghasemzadeh-Moghaddam H, Neela V, van Wamel W, Hamat RA, Shamsudin MN, Hussin NS, et al. Nasal carriers are more likely to acquire exogenous Staphylococcus aureus strains than non-carriers. Clin Microbiol Infect. 2015; 21(11): 9981-7[DOI][PubMed]
  • 6. Otsuka T, Zaraket H, Takano T, Saito K, Dohmae S, Higuchi W, et al. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan. Clin Microbiol Infect. 2007; 13(3): 325-7[DOI][PubMed]
  • 7. Shoji K, Shinjoh M, Horikoshi Y, Tang J, Watanabe Y, Sugita K, et al. High rate of inducible clindamycin resistance in Staphylococcus aureus isolates--a multicenter study in Tokyo, Japan. J Infect Chemother. 2015; 21(2): 81-3[DOI][PubMed]
  • 8. Schreckenberger PC, Ilendo E, Ristow KL. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol. 2004; 42(6): 2777-9[DOI][PubMed]
  • 9. Chavez-Bueno S, Bozdogan B, Katz K, Bowlware KL, Cushion N, Cavuoti D, et al. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother. 2005; 49(6): 2283-8[DOI][PubMed]
  • 10. Lewis JS, Jorgensen JH. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis. 2005; 40(2): 280-5[DOI][PubMed]
  • 11. Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother. 1999; 43(5): 1062-6[PubMed]
  • 12. Prunier AL, Malbruny B, Tande D, Picard B, Leclercq R. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. . Antimicrob Agents Chemother. 2002; 46(9): 3054-6[DOI]
  • 13. Cetin ES, Gunes H, Kaya S, Aridogan BC, Demirci M. Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates. Int J Antimicrob Agents. 2008; 31(4): 364-8[DOI][PubMed]
  • 14. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother. 1999; 43(12): 2823-30[PubMed]
  • 15. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 2003; 41(10): 4740-4[PubMed]
  • 16. Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother. 2001; 48(2): 315-6[PubMed]
  • 17. Ghasemzadeh-Moghaddam H, Ghaznavi-Rad E, Sekawi Z, Yun-Khoon L, Aziz MN, Hamat RA, et al. Methicillin-susceptible Staphylococcus aureus from clinical and community sources are genetically diverse. Int J Med Microbiol. 2011; 301(4): 347-53[DOI][PubMed]
  • 18. Neela V, Ehsanollah GR, van Belkum A, Mariana NS, Zamberi S. Prevalence of Staphylococcus aureus carrying Panton-Valentine leukocidin genes among carriage and invasive isolates in Malaysia. Int J Infect Dis. 2009; 13(3): 131-2[DOI]
  • 19. Martineau F, Picard FJ, Roy PH, Ouellette M, Bergeron MG. Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus. J Clin Microbiol. 1998; 36(3): 618-23[PubMed]
  • 20. VasanthaKumari N, Alshrari AS, Rad EG, Moghaddam HG, van Belkum A, Alreshidi MA, et al. Highly dynamic transient colonization by Staphylococcus aureus in healthy Malaysian students. J Med Microbiol. 2009; 58: 1531-2[DOI][PubMed]
  • 21. M02-A10 Performance standards for antimicrobial disk susceptibility tests; approved standard-tenth edition. 2009;
  • 22. Martineau F, Picard FJ, Lansac N, Menard C, Roy PH, Ouellette M, et al. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 2000; 44(2): 231-8[PubMed]
  • 23. Strommenger B, Kettlitz C, Werner G, Witte W. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol. 2003; 41(9): 4089-94[PubMed]
  • 24. Castro-Alarcon N, Ribas-Aparicio RM, Silva-Sanchez J, Calderon-Navarro A, Sanchez-Perez A, Parra-Rojas I, et al. Molecular typing and characterization of macrolide, lincosamide and streptogramin resistance in Staphylococcus epidermidis strains isolated in a Mexican hospital. J Med Microbiol. 2011; 60: 730-6[DOI][PubMed]
  • 25. O’Sullivan MVN, Cai Y, Kong F, Zeng X, Gilbert GL. Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp. J Clin Microbiol. 2006; 44(11): 4072-6[PubMed]
  • 26. Osman M, Al Nasbeh A, Rafei R, Mallat H, Achkar M, Dabboussi F. Characterization of resistance genes to macrolides, lincosamides and streptogramins (MLS) among clinical isolates of Staphylococcus aureus in North Lebanon. IJAAA. 2015; 5(4.3)[DOI]
  • 27. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002; 34(4): 482-92[PubMed]
  • 28. Prabhu K, Rao S, Rao V. Inducible Clindamycin Resistance in Staphylococcus aureus Isolated from Clinical Samples. J Lab Physicians. 2011; 3(1): 25-7[DOI][PubMed]
  • 29. Uzunovic S, Ibrahimagic A, Kamberovic F, Kunarac M, Rijnders MI, Stobberingh EE. Inducible clindamycin resistance in methicillin-susceptible and methicillin-resistant Staphylococcus aureus of inpatient, outpatient and healthy carriers in Bosnia and Herzegovina. Med Glas (Zenica). 2013; 10(2): 217-24[PubMed]
  • 30. Durmaz S, Kiraz A, Toka OT, Percin D. Macrolide-lincosamide-streptogramin b resistance phenotypes in staphylococcus aureus. Eur J Gen Med. 2014; 11(4): 217-20[DOI]
  • 31. Saribas Z, Tunckanat F, Pinar A. Prevalence of erm genes encoding macrolide-lincosamide-streptogramin (MLS) resistance among clinical isolates of Staphylococcus aureus in a Turkish university hospital. Clin Microbiol Infect. 2006; 12(8): 797-9[DOI][PubMed]
  • 32. Spiliopoulou I, Petinaki E, Papandreou P, Dimitracopoulos G. erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece. J Antimicrob Chemother. 2004; 53(5): 814-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments